Recent developments and rationale towards new strategies for malarial chemotherapy

Parasite

Volumn 3, Issue 1, 1996, Pages 3-23

  Vial, H ^a  

^a CNRS   (France)

Author keywords

Antimalarials; Molecular structure of the target; New drug concepts; Phospholipid; Purine; Pyrimidine; Replication

Indexed keywords

ANTIMALARIAL AGENT;

ANIMAL; HUMAN; MALARIA; METABOLISM; MOLECULAR BIOLOGY; PARASITOLOGY; PHYSIOLOGY; PLASMODIUM FALCIPARUM; REVIEW; ULTRASTRUCTURE;

ANIMALS; ANTIMALARIALS; HUMANS; MALARIA; MOLECULAR BIOLOGY; PLASMODIUM FALCIPARUM;

EID: 0030099836     PISSN: 1252607X     EISSN: None     Source Type: Journal    
DOI: 10.1051/parasite/1996031003     Document Type: Article

References (148)

1. ANCELIN M.L., PARENT M., THUET M.J., PHILIPPOT J.R. & VIAL H.J. Increased permeability to choline in simian erythrocytes after Plasmodium knowlesi infection. Biochemical Journal, 1991, 701-709.
2. ANCELIN M.L. & VIAL H.J. Quaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vivo by impairment of choline transport. Antimicrobial Agents and Chemotherapy, 1986, 814-820.
3. ANCELIN M.L. & VIAL H.J. Regulation of phosphatidylcholine biosynthesis in Plasmodium-infected erythrocytes. Biochimica et Biophysica Acta, 1989, 82-89.
4. ANCELIN M.L., VIAL H.J. & PHILIPPOT J.R. Inhibitors of choline transport into Plasmodium-infected erythrocytes are effective antiplasmodial compounds in vitro. Biochemical Pharmacology, 1985, 4068-4071.
5. ANDREWS P. Functional groups drug-receptor interactions and drug design. Trends in Pharmaceutical Science, 1986, 148-151.
6. ASAWAMAHASAKDA W., ITTARAT I., PU Y.M., ZIFFER H. & MESHNICK S.R. Reaction of antimalarial endoperoxides with specific parasite proteins, Antimicrobial Agents and Chemotherapy, 1994, 1854-1858.
7. ATAMNA H. & GINSBURG H. Origin of reactive oxygen species in erythrocytes infected with Plasmodium falciparum. Molecular and Biochemical Parasitolology, 1993, 231-242.
8. ATAMNA H., PASCARMONA G. & GINSBURG H. Hexose-monophosphate shunt activity in intact Plasmodium falciparum infected erythrocytes and in free parasites. Molecular and Biochemical Parasitology, 1994, 79-89.
9. BAILLY E., JAMBOU R., SAVEL J. & JAUREGUIBERRY G. Plasmodium falciparum - Differential Sensitivity in vitro to E-64 (Cysteine Protease Inhibitor) and Pepstatin-A (Aspartyl Protease Inhibitor). Journal of Protozoology, 1992, 593-599.
10. BANNISTER L.H. & MITCHELL G.H. The role of the cytoskeleton in Plasmodium falciparum merozoite biology: An electron-microscopic view. Annals of Tropical Medicine and Parasitology, 1995, 105-111.
11. BEAUMELLE B.D. & VIAL H.J. Correlation of the efficiency of fatty derivatives in suppressing Plasmodium falciparum growth in culture with their inhibitory effect on acyl-CoA synthetase activity. Molecular and Biochemical Parasitology, 1988, 39-42.
12. BECUWE P., SLOMIANNY C., CAMUS D. & DIVE D. Presence of an endogenous Superoxide dismutase activity in 3 rodent malaria species. Parasitology Research, 1993, 349-352.
13. BEUTLER E. G6PD deficiency. Blood, 1994, 3613-3636.
14. BRETON C.B., BLISNICK T., JOUIN H., BARALE J.C., RABILLOUD T. et al. Plasmodium chabaudi p68 Serine Protease Activity Required for Merozoite Entry into Mouse Erythrocytes. Proceedings of the National Academy of Sciences USA, 1992, 9647-9651.
15. BRETON C.B. & PEIRERA DA SILVA L.H. Plasmodium and the Infected Erythrocyte - Malaria Proteases and Red Blood Cell Invasion. Parasitology Today, 1993, 92-96.
16. BROOKS D.R., WANG P., READ M., WATKINS W.M., SIMS P.F.G. et al. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: Dihydropteroate synthase gene in line so the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. European Journal of Biochemistry, 1994, 397-405.
17. BUFFINTON G.D., HUNT N., COWDEN W. & CLARK A. Malaria: a role for reactive oxygen species in parasite killing and host pathology in Free radicals, Cell damage and Disease. Rice-Evans C., ed. Richelieu Press, London, 1986, 201-220.
18. BUNNAG D., POLTERA A.A., VIRAVAN C., LOOAREESUWAN S., HARINASUTA K.T. et al. Plasmodicidal Effect of Desferrioxamine-B in Human Vivax or Falciparum malaria from Thailand. Acta Tropica, 1992, 59-67.
19. BZIK D.J., FOX B.A. & GONYER K. Expression of Plasmodium-Falciparum Lactate Dehydrogenase in Escherichia-Coli, Molecular and Biochemical Parasitology, 1993, 155-166.
20. CABANTCHIK Z.I. Altered membrane transport of malaria-infected erythrocytes: A possible pharmacological target, Blood, 1989, 1464-1471.
21. CABANTCHIK Z.I. Iron chelators as antimalarials: The biochemical basis of selective cytotoxicity. Parasitology Today, 1995, 74-78.
22. CHAKRABARTI D., SCHUSTER S.M. & CHAKRABARTI R. Cloning and Characterization of Subunit Genes of Ribonucleotide Reductase, a Cell-Cycle-Regulated Enzyme, from Plasmodium falciparum. Proceedings of the National Academy of Sciences USA, 1993, 12020-12024.
23. CHAVALITSHEWINKOON P., DEVRIES E., STAM J.G., FRANSSEN F.F.J., VANDERVLIET P.C. et al. Purification and Characterization of DNA Polymerases from Plasmodium falciparum. Molecular and Biochemical Parasitology, 1993, 243-253.
24. CLARK D., CHRISEY J., CAMPBELL E. & DAVIDSON E. Non-sequence-specific antimalarial activity of oligodeoxynucleotides. Molecular and Biochemical Parasitology, 1994, 129-134.
25. CLEMENS M. & WALLER H. Lipid peroxydation in erythrocytes. Chemistry and Physics of Lipids, 1987, 251-268.
26. COLLINS F. & PASKEWITZ M. Malaria: current and future prospects for control. Annales de la Revue d'Entomologie, 1995, 195-219.
27. COOMBER D.W.J., OSULLIVAN W.J. & GERO A.M. Adenosine Analogues as Antimetabolites Against Plasmodium falciparum Malaria. International Journal for Parasitology, 1994, 357-365.
28. COWMAN A.F. & FOOTE S.J. Chemotherapy and drug resistance in malaria. International Journal for Parasitology, 1990, 503-513.
29. DELPLACE P., BHATIA A., CAGNARD M., CAMUS D. & COLOMBET G. Protein 126: a parasitophorous vacuole antigen associated with the release of Plasmodium falciparum merozoites, Biol. Cell, 1986, 215-221.
30. DORN A., STOFFEL R., MATILE H., BUBENDORF A. & RIDLEY R.G. Malarial haemozoin beta-haematin supports haem polymerization in the absence of protein. Nature, 1995, 269-271.
31. EADS J., SCAPIN G., XU Y., GRUBMEYER C. & SACCHETTINI J. The crystal structure of human hypoxanthine-guanosine phosphoribosyltransferase with bound GMP. Cell, 1994, 325-334.
32. EAKIN A.E., NIEVESALICEA R., TOSADOACEVEDO R., CHIN M.S., WANG C.C. et al. Comparative complement selection in bacteria enables screening for lead compounds targeted to a purine salvage enzyme of parasites. Antimicrobial Agents and Chemotherapy, 1995, 620-625.
33. ELFORD B., COWAN G. & FERGUSON D. Parasite-regulated membrane transport processes and metabolic control in malaria-infected-erythrocytes. Biochemical Journal, 1995, 361-374.
34. ELLIS J.E. Coenzyme Q homologs in parasitic protozoa as targets for chemotherapeutic attack. Parasitology Today, 1994, 296-301.
35. FAIRFIELD A., ABOSCH A., RANZ A., EATON J. & MESHNICK S. Oxidant defense enzymes of Plasmodium falciparum. Molecular and Biochemical Parasitology, 1988, 77-82.
36. FLORES M.V.C., OSULLIVAN W.J. & STEWART T.S. Characterisation of the carbamoyl phosphate synthetase gene from Plasmodium falciparum. Molecular and Biochemical Parasitology, 1994, 315-318.
37. FOWLER R., SINDEN R. & PUDNEY M. Inhibitory activity of the anti-malarial atovaquone (566C80) against ookinetes, oocysts, and sporozoites of Plasmodium berghei. Journal of Parasitology, 1995, 452-458.
38. FRANCIS S.E., GLUZMAN I.Y., OKSMAN A., KNICKERBOCKER A., MUELLER R. et al. Molecular characterization and inhibition of a Plasmodium falciparum aspartic protease. EMBO Journal, 1994, 306-317.
39. FRITSCH G., TREUMER J., SPIRA D. & JUNG A. Plasmodium vinckei: suppression of mouse infections with desferrioxamine B Experimental Parasitology. Experimental Parasitology, 1985, 171-176.
40. FRY M. & PUDNEY M. Site of action of the antimalarial hydroxynaphtoquinone, 566C80. Biochemical Pharmacology, 1992.
41. GABAY T. & GINSBURG H. Hemoglobin denaturation and iron release in acidified red blood cell lysate - a possible source of iron for intraerythrocytic malaria parasites. Experimental Parasitology, 1993, 261-272.
42. GABAY T., KRUGLIAK M., SHALMIEV G. & GINSBURG H. Inhibition by anti-malarial drugs of haemoglobin denaturation and iron release in acidified red blood cell lysates. A possible mechanism of their antimalarial effect. Parasitology, 1994, 371-381.
43. GAMAGE S., TEPSIRI N., WILAIRAT P., WOJCIK S., FIGGIT P. et al. Synthesis and in vitro evaluation of 9-anilino-3,6-diami- noacridines active against a multidrug-resistant strain of the malaria-parasite Plasmodium falciparum. Journal of Medicinal Chemistry, 1994, 1486-1494.
44. GATI W.P., A.N. L., WANG T.I., YOUNG J.D. & PATERSON A.R. Parasite-induced processes for adenosine permeation in mouse erythrocytes infected with the malarial parasite Plasmodium yoelii. Biochemical Journal, 1990, 277-280.
45. GERO A.M. & KIRK K. Nutrient transport pathways in Plasmodium infected erythrocytes: What and where are they? Parasitology Today, 1994, 395-399.
46. GERO A.M. & O'SULLIVAN W.J. Purines and Pyrimidines in Malarial Parasites, Blood Cells, 1990, 467-484.
47. GERO A.M. & UPSTON J.M. Altered membrane permeability: a new approach to malaria chemotherapy. Parasitology Today, 1992, 283-286.
48. GINSBURG H. Malaria and the red blood cell, Vol. 16. Springer International, Wien, 1990, 628 p.
49. GINSBURG H. & ATAMNA H. The redox status of malaria-infected erythrocytes: an overview with an emphasis on unresolved problem. Parasite, 1994, 5-13.
50. GINSBURG H., GORODETSKY R. & KRUGLIAK M. The status of zinc in malaria (Plasmodium falciparum) infected human red blood cells: stage-dependent accumulation, compartmentation and the effect of dipicolinate. Biochimica et Biophysica Acta, 1986, 337-344.
51. GLUZMAN I.Y., FRANCIS S.E., OKSMAN A., SMITH C., DUFFIN K. et al. Order and specificity of the Plasmodium hemoglobin degradation pathways. Journal of Clinical Investigation, 1994, 1602-1607.
52. GOLDBERG D.E. Plasmodial Hemoglobin Degradation - An Ordered Pathway in a Specialized Organelle. Infectious Agent Diseases, 1992, 207-211.
53. GOLENSER J. & CHEVION M. Oxidant stress and malaria: host-parasite interrelationships in normal and abnormal erythrocytes. Seminars in Hematology, 1989, 313-325.
54. GOLENSER J., TSAFACK A., AMICHAI Y., LIBMAN J., SHANZER A. et al. Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores. Antimicrobial Agents and Chemotherapy, 1995, 61-65.
55. GORDEUK V., THUMA P., BRITTENHAM G., MCLAREN C., PARRY D. et al. Effect of Iron Chelation Therapy on Recovery from Deep Coma in Children with Cerebral Malaria. New England Journal of Medicine, 1992, 1473-1477.
56. GORDEUK V.R., THUMA P.E., BRITTENHAM G.M., BIEMBA G., ZULU S. et al. Iron Chelation as a Chemotherapeutic Strategy for Falciparum malaria. American Journal of Tropical Medicine and Hygiene, 1993, 193-197.
57. GRELLIER P., VALENTIN A., MILLERIOUX V., SCHREVEL J. & RIGOMIER D. 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase Inhibitors Lovastatin and Simvastatin Inhibit in vitro Development of Plasmodium falciparum and Babesia Divergens in Human Erythrocytes. Antimicrobial Agents and Chemotherapy, 1994, 1144-1148.
58. HALDAR K., HENDERSON C. & CROSS G. Identification of the parasite transferrin receptors of P. falciparum infected erythrocytes and its acylation via 1,2-diacyl-sn-glycerol. Proceedings of the National Academy of Sciences USA, 1986, 8565-8569.
59. HIEN T.T. & WHITE N.J. Qinghaosu. Lancet, 1993, 603-608.
60. HOLDER A.A., BLACKMAN M.J., BORRE M., BURGHAUS P.A., CHAPPEL J.A. et al. Malaria parasites and erythrocyte invasion. Biochemical Society Transactions, 1994, 291-295.
61. HOLZ G.G. Lipids and the malaria parasite. Bulletin of the WHO, 1977, 237-248.
62. HUDSON A.T. Atovaquone. A novel broad-spectrum anti-infective drug. Parasitology Today, 1993, 66-68.
63. HUNT N.H. & STOCKER R. Oxidative stress and the redox status of malaria-infected erythrocytes. Blood Cells, 1990, 499-526.
64. JAMES E. Superoxyde dismutase. Parasitology Today, 1994, 481-484.
65. KAIDOH T., NATH J., FUJIOKA H., OKOYE V. & AIKAWA M. Effect and localization of trifluralin in Plasmodium falciparum gametocytes: An electron microscopic study. The Journal of Eukaryotic Microbiology, 1995, 61-64.
66. KAMCHONWONGPAISAN S., VANITCHAREON N. & YUTHAVONG Y. The Mechanism of Antimalarial Action of Artemisinin (Qinghaosu). In: Lipid. Soluble Antioxidants: Biochemistry and Clinical Applications. (Ong A.S.H. & Packer L., eds.), Birkhauser Verlag, Basel, 1992, 363-372.
67. KING A. & MELTON D.W. Characterization of cDNA clones for hypoxanthine-guanine phosphoribosyltransferase from the human malarial parasites, P. falciparum: comlparison to the mammalain gene and protein. Nucleic Acids Research, 1987, 10469-10481.
68. KROGSTAD D.J., SUZUKI M., LONG C.A., AOKI Y., ISHII A. et al. Drug discovery, development and deployment: A report from the 28th joint conference of the US-Japan Parasitic Diseases Panels, Baltimore, Maryland, July 1993. American Journal of Tropical Medicine and Hygiene, 1994, 384-388.
69. KRUNGKRAI J. Purification, characterization and localization of mitochondrial dihydroorotate dehydrogenase in Plasmodium falciparum, human malaria parasite. Biochimica et Biophysica Acta, 1995, 351-360.
70. KRUNGKRAI S.R. & YUTHAVONG Y. The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents which modulates oxidant stress. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1987, 710-714.
71. LOYEVSKY M., LYTTON S.D., MESTER B., LIBMAN J., SHANZER A. et al. The Antimalarial Action of Desferal Involves a Direct Access Route to Erythrocytic (Plasmodium falciparum) Parasites. Journal of Clinical Investigation, 1993, 218-224.
72. LYTTON S.D., MESTER B., LIBMAN J., SHANZER A. & CABANTCHIK Z.I. Mode of action of iron (III) chelators as antimalarials. 2. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis. Blood, 1994, 910-915.
73. MAESSEN S., WESSELING J.G., SMITS M.A., KONINGS R.N.H. & SCHOENMAKERS J.G.G. The gamma-Tubulin Gene of the Malaria Parasite Plasmodium falciparum. Molecular and Biochemical Parasitology, 1993, 27-36.
74. MARTIN S.K. The malaria/G6PD hypothesis revisited. Parasitology Today, 1994, 251-252.
75. MAURICE J. Malaria vaccine raises a dilemma. Science, 1995, 320-323.
76. MCCONKEY G.A., ITTARAT I., MESHNICK S.R. & MCCUTCHAN T.F. Auxotrophs of Plasmodium falciparum dependent on p-aminobenzoic acid for growth. Proceedings of the National Academy of Sciences USA, 1994, 4244-4248.
77. MCKERROW J.H., SUN E., ROSENTHAL P.J. & BOUVIER J. The Proteases and Pathogenicity of Parasitic Protozoa. Annual Review of Microbiology, 1993, 821-853.
78. MESHNICK S.R. The mode of action of antimalarial endoperoxides. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1994, 31-32.
79. MESHNICK S.R., RANZ A., THOMAS A., XU C.M. & PAN H.Z. Artemisinin (qinghaosu): the role of hemin in its mechanism of antimalarial action. Molecular and Biochemical Parasitology, 1991, 181-190.
80. MESHNICK S.R., YANG Y.Z., LIMA V., KUYPERS F., KAMCHONWONGPAISAN S. et al. Iron-Dependent Free Radical Gene-ration from the Antimalarial Agent Artemisinin (Qinghaosu). Antimicrobial Agents and Chemotherapy, 1993, 1108-1114.
81. MOLL G.N., VAN DEN EERTWEGH V., TOURNOIS H., ROELOFSEN B., OP DEN KAMP J.A.B, et al. Growth inhibition of Plasmodium falciparum in vitro cultures by selective action of trytophan-N-formylated gramicidin incorporated in lipid vesicles. Biochimica et Biophysica Acta, 1991, 206-210.
82. MUHIA D.K., THOMAS G.G., WARD S.A., EDWARDS G., MBERU E.K. et al. Ferriprotoporphyrin catalysed decomposition of artemether: Analytical and pharmacological implications. Biochemical Pharmacology, 1994, 889-895.
83. NAKORNCHAI S. & ANANTAVARA S. Oxygen free radicals in malaria. In: Lipid-Soluble Antioxidants. Biochemistry and Clinical Applications. Ong A.S.H. Packer L. (eds), Birkhauser Verlag, Basel, 1992, 355-362.
84. OLLIARO P. & GOLDBERG D. The Plasmodium digestive vacuole: metabolic headquarters and choice drug target. Parasitology Today, 1995, 294-297.
85. OLLIARO P. & TRIGG P. Status of antimalarial drugs under development. Bulletin of the WHO, 1995, 565-571.
86. PHILLIPSON J.D. Natural products as drugs. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1994, 17-19.
87. POLLACK S., ROSAN D., DAVIDSON D. & ESCAJADILLO A. Desferrioxamine suppresses P. falciparum in Aotus monkeys. Proc. Soc. Exp. Biol. Med., 1987, 162-164.
88. POLLACK S. & SCHNELLE. Inability to detect transferrin receptors on P. falciparum parasitized red cells. British Journal of Haematology, 1988, 125-129.
89. POSNER G.H., OH C.H., WEBSTER H.K., AGER A.L. & ROSSAN R.N. New, antimalarial, tricyclic 1,2,4-trioxanes: Evaluations in mice and monkeys. American Journal of Tropical Medicine and Hygiene, 1994, 522-526.
90. POUVELLE B., PARLEY P.J., LONG C.A. & TARASCHI T.F. Taxol arrests the development of blood-stage Plasmodium falciparum in vitro and Plasmodium chabaudi adami in malaria-infected mice. Journal of Clinical Investigation, 1994, 413-417.
91. PUSSARD E. & VERDIER F. Antimalarial 4-Aminoquinolines. Mode of Action and Pharmacokinetics. Fundamental and Clinical Pharmacology, 1994, 1-17.
92. QUEEN S., JAFT D. & REYES P. Characterization of adenine phosphoribosyltransferase from the human malaria parasite, Plasmodium falciparum. Biochimica et Biophysica Acta, 1989, 160-165.
93. RANZ A. & MESHNICK S. Plasmodium falciparum inhibitor sensitivity of the endogenous Superoxide dismutase. Experimental Parasitology, 1989, 125-128.
94. RATHOD P.K., KHOSLA M., GASSIS S., YOUNG R.D. & LUTZ C. Selection and characterization of 5-fluoroorotate-resistant Plasmodium falciparum. Antimicrobial Agents and Chemotherapy, 1994, 2871-2876.
95. RATHOD P.K. & RESHMI S. Susceptibility of Plasmodium Falciparum to a Combination of Thymidine and ICI D1694, a Quinazoline Antifolate Directed at Thymidylate Synthase. Antimicrobial Agents and Chemotherapy, 1994, 476-480.
96. READ M., SHERWIN T., HOLLOWAY S.P., GULL K. & HYDE J.E. Microtubular Organization Visualized by Immunofluorescence Microscopy During Erythrocytic Schizogony in Plasmodium falciparum and Investigation of Post-Translational Modifications of Parasite Tubulin. Parasitology, 1993, 223-232.
97. RIOU J., GABILLOT M., PHILIPPE M., SCHREVEL J. & RIOU G. Purification and characterization of Plasmodium berghei DNA topoisomerase I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage. Biochemistry, 1986, 1471-1479.
98. ROOSE J.P. & VANNOORDEN C.J.F. Synthetic protease inhibitors: Promising compounds to arrest pathobiologic processes. Journal of Laboratory and Clinical Medicine, 1995, 433-441.
99. ROSENTHAL P., LEE G. & SMITH R. Inhibition of a Plasmodium vinckei cysteine proteinase cures malaria. Journal of Clinical Investigation, 1993, 1052-1056.
100. ROSENTHAL P.J. Plasmodium falciparum: Effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites. Experimental Parasitology, 1995, 272-281.
101. ROSENTHAL P.J. & NELSON R.G. Isolation and characterization of a cysteine protease gene of Plasmodium falciparum. Molecular and Biochemical Parasitology, 1992, 143-152.
102. ROSENTHAL P.J., RING C.S., CHEN X.W. & COHEN F.E. Characterization of a Plasmodium vivax cysteine proteinase gene identifies uniquely conserved amino acids that may mediate the substrate specificity of malarial hemoglobinases. Journal of Molecular Biology, 1994, 312-316.
103. ROSENTHAL P.J., WOLLISH W.S., PALMER J.T. & RASNICK D. Anti-malarial Effects of Peptide Inhibitors of a Plasmodium falciparum Cysteine Proteinase. Journal of Clinical Investigation, 1991, 1467-1472.
104. ROTH E.J. Plasmodium falciparum carbohydrate metabolism: a connection between host and parasite. Blood Cells, 1990, 453-460.
105. RUBIN H., SALEM J.S., LI L.S., YANG F.D., MAMA S. et al. Cloning, Sequence Determination, and Regulation of the Ribonucleotide Reductase Subunits from Plasmodium falciparum. A Target for Antimalarial Therapy. Proceedings of the National Academy of Sciences USA, 1993, 9280-9284.
106. RUWENDE C., KHOO S., SNOW R., YATES S., KWIATKOWSKI D. et al. Natural selection of hemi-and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature, 1995, 246-249.
107. SALAS F., FICHMANN J., LEE G.K., SCOTT M.D. & ROSENTHAL P.J. Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase. Infection and Immunity, 1995, 2120-2125.
108. SANCHEZLOPEZ R. & HALDAR K. A Transferrin-Independent Iron Uptake Activity in Plasmodium-Falciparum-Infected and Uninfected Erythrocytes. Molecular and Biochemical Parasitology, 1992, 9-20.
109. SANO G., MORIMATSU K. & HORII T. Purification and Characterization of Dihydrofolate Reductase of Plasmodium falciparum Expressed by a Synthetic Gene in Escherichia coli. Molecular and Biochemical Parasitology, 1994, 265-273.
110. SCHIRMER R.H., MULLER J.G. & KRAUTHSIEGEL R.L. Disulfide-reductase inhibitors as chemotherapeutic agents: The design of drugs for trypanosomiasis and malaria. Angew Chem Int Ed, 1995, 141-154.
111. SCHLESINGER P., KROGSTAD D. & HERWALDT B. Antimalarial agents: mechanism of action, Antimicrobial Agents and Chemotherapy, 1988, 793-798.
112. SCHREVEL J., DEGUERCY A., MEYER R. & MONSIGNY M. Proteases in malaria-infected red cells. Blood Cells, 1990, 563-584.
113. SCHREVEL J., SINOU V., GRELLIER P., FRAPPIER F., GUENARD D. et al. Interactions between docetaxel (Taxotere) and Plasmodium falciparum-infected erythrocytes. Proceedings of National Academy of Sciences USA, 1994, 8472-8476.
114. SCOTT M.D., MESHNICK S.R., WILLIAMS R.A., CHIU D.T.Y., PAN H.C. et al. Quinghaosu-mediated oxidation in normal and abnormal erythrocytes. Journal of Laboratory and Clinical Medicine, 1989, 401-406.
115. SEYMOUR K.K., LYONS S.D., PHILLIPS L., RIECKMANN K.H. & CHRISTOPHERSON R.I. Cytotoxic Effects of Inhibitors of de novo Pyrimidine Biosynthesis upon Plasmodium falciparu. Biochemistry, 1994, 5268-5274.
116. SHERMAN I. Biochemistry of Plasmodium (malarial parasite), Microbiology Review, 1979, 453-495.
117. SHERMAN I.W. Metabolism, In: Peters W. and Richards W. (eds). Springer Verlag, Berlin, 1984, 31-71.
118. SILPHEN J., YANAI P. & CABANTCHIK Z.I. Bioflavonoid effects on in vitro cultures of Plasmodium falciparum. Inhibition of permeation pathways induced in the host cell membrane by the intraerythrocytic parasite. Biochemical Pharmacology, 1988, 4269-4276.
119. SIMOES A.P.C.F., VANDERBERG J.J.M., ROELOFSEN B. & OPDENKAMP J.A.F. Lipid peroxidation in Plasmodium falciparum parasitized human erythrocytes. Archives of Biochemistry and Biophysics, 1992, 651-657.
120. SIRAWARAPORN W., PRAPUNWATTANA P., SIRAWARAPORN R., YUTHA- VONG Y. & SANTI D.V. The Dihydrofolate Reductase Domain of Plasmodium falciparum Thymidylate Synthase-Dihydrofolate Reductase-Gene Synthesis, Expression, and Anti-Folate-Resistant Mutants. Journal of Biological Chemistry, 1993, 21637-21644.
121. SLATER A.F.G. & CERAMI A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature, 1992, 167-169.
122. SMEIJSTERS L.J.J.W., ZIJLSTRA N.M., DEVRIES E., FRANSSEN F.F.J., JANSE C.J. et al. The effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl) adenine on nuclear and organellar DNA synthesis in erythrocytic schizogony in malaria. Molecular and Biochemical Parasitology, 1994, 115-124.
123. SPENCER C. & KL G. Atovaquone. A review of its pharmacological properties and therapeutic efficacy in Opportunistis Infections. Drugs, 1995, 176-196.
124. SUN E. & COHEN F.E. Computer-Assisted Drug Discovery. A Review. Gene, 1993, 127-132.
125. TANNER M., TEUSCHER T. & ALONSO P.L. SPf66 - The first malaria vaccine. Parasitology Today, 1995, 10-13.
126. TRAORE O., CARNEVALE P., KAPTUE N., BEDE J., DESFONTAINE J. et al. Preliminary reporst on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria. American of Journal of Hematology, 1991, 206-208.
127. TRIGLIA T. & COWMAN A.F. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proceedings of the National Academy of Sciences USA, 1994, 7149-7153.
128. TSAFACK A., GOLENSER J., LlBMAN J., SHANZER A. & CABANTCHIK Z.I. Mode of action of iron(III) chelators as antimalarials. 3. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum. Molecular Pharmacology, 1995, 403-409.
129. TURRINI F., GINSBURG H., BUSSOLINO F., PESCARMONA G.P., SERRA M.V. et al. Phagocytosis of Plasmodium falciparum infected human red blood cells by human monocytes-involvement of immune and nonimmune determinants and dependence on parasite developmental stage. Blood, 1992, 801-808.
130. ULLMAN B. & CARTER D. Hypoxanthine-guanine phosphoribosyltransferase as a therapeutic target in protozoal infections. Infectious Agent Diseases, 1995, 29-40.
131. VAIDYA A.B., LASHGARI M.S., POLOGE L.G. & MORRISEY J. Structural Features of Plasmodium Cytochrome-b That May Underlie Susceptibility to 8-Aminoquinolines and Hydroxynaphthoquinones. Molecular and Biochemical Parasitology, 1993, 33-42.
132. VAN DYKE K. Purines and pyrimidines in malarial parasites-commentary. Blood Cells, 1990, 485-495.
133. VANZYL R.L., HAVLIK I., HEMPELMANN E., MACPHAIL A.P. & MCNAMARA L. Malaria Pigment and Extracellular Iron - Possible Target for Iron Chelating Agents. Biochemical Pharmacology, 1993,
134. VASANTHAKUMAR G., DAVIS R.L., SULLIVAN M.A. & DONAHUE J. Cloning and expression in Escherichia coli of a hypoxanthine-guanine phosphoribosyltransferase-encoding cDNA from Plasmodium falciparum. Gene, 1991, 63-69.
135. VENNERSTROM J.L. & EATON J.W. Oxidants, oxidant drugs, and malaria. Journal of Medicinal Chemistry, 1988, 1269-1277.
136. VIAL H.J. & ANCELIN M.L. Malarial Lipids, an overview, In: Subcellular Biochemistry. Avila J.L. & Harris J.R. (eds), Plenum Press, New York, 1992, 259-306.
137. VIAL H.J., ANCELIN M.L., PHILIPPOT J.R. & THUET M.J. Biosynthesis and Dynamics of lipids in Plasmodium infected mature mammalian erythrocytes. Blood Cells, 1990, 531-555.
138. VIAL H.J., THUET M.J., ANCELIN M.L., PHILIPPOT J.R. & CHAVIS C. Phospholipid metabolism as a new target for malaria chemotherapy. Mecanism of action of D-2-amino-1-butanol. Biochemical Pharmacology, 1984, 2761-2770.
139. WANG P., BROOKS D.R., SIMS P.F.G. & HYDE J.E. A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Molecular and Biochemical Parasitology, 1995, 115-125.
140. WANG T.F. Eukaryotic DNA polymerases. Annual Review of Biochemistry, 1991, 513-532.
141. WEI N.M. & SADRZADEH S.M.H. Enhancement of hemin-induced membrane damage by artemisinin. Biochemical Pharmacology, 1994, 737-741.
142. WELLEMS T.E. Molecular genetics of drug resistance in Plasmodium falciparum malaria. Parasitology Today, 1991, 110-121.
143. WERNDORFER W.H. & PAYNE D. The dynamics of drug resistance in Plasmodium falciparum. Pharmaceutical Therapy, 1991, 95-121.
144. WHITE J.H., KILBEY B.J., DEVRIES E., GOMAN M., ALANO P. et al. The Gene Encoding DNA Polymerase-alpha from Plasmodium falciparum. Nucleic Acids Research, 1993, 3643-3646.
145. WHITE N.J. Antimalarial pharmacokinetics and treatment regimens. British Journal of Clinical Pharmacology, 1992, 1-10.
146. WOERDENBAG H.J., PRAS N., VANUDEN W., WALLAART T.E., BEEKMAN A.C. et al. Progress in the Research of Artemisinin-Related Antimalarials - An Update. Pharmacology World Sciences, 1994, 169-180.
147. YANG Y.Z., LITTLE B. & MESHNICK S.R. Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure. Biochemical Pharmacology, 1994, 569-573.
148. ZHANG F., GOSSER D. & MESHNICK S.R. Hemin-catalyzed decomposition of artemisinin (qinghaosu). Biochemical Pharmacology, 1992, 1805-1809.